Kazui Hiroaki, Hashimoto Mamoru, Takeda Shigetoshi, Chiba Yasuji, Goto Tokiko, Fuchino Katsuhiro
Department of Neuropsychiatry, Kochi Medical School, Kochi University, Nankoku, Japan.
Department of Neuropsychiatry, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Front Neurol. 2022 May 27;13:810116. doi: 10.3389/fneur.2022.810116. eCollection 2022.
Treatment of idiopathic normal-pressure hydrocephalus (iNPH) requires collaboration between dementia specialists and neurosurgeons. The role of dementia specialists is to differentiate patients with iNPH from patients with other dementia diseases and to determine if other dementia diseases are comorbid with iNPH. We conducted a nationwide hospital-based questionnaire survey on iNPH in medical centers for dementia (MCDs).
We developed a questionnaire to assess how physicians in MCDs evaluate and treat patients with cognitive impairment due to suspected iNPH and the difficulties these physicians experience in the evaluation and treatment of patients. The questionnaire was sent to all 456 MCDs in Japan.
Questionnaires from 279 MCDs were returned to us (response rate: 61.2%). Patients underwent cognitive tests, evaluation of the triad symptoms of iNPH, and morphological neuroimaging examinations in 96.8, 77.8, and 98.2% of the MCDs, respectively. Patients with suspected iNPH were referred to other hospitals (e.g., hospitals with neurosurgery departments) from 78.9% of MCDs, and cerebrospinal fluid (CSF) tap test was performed in 44 MCDs (15.8%). iNPH guidelines (iNPHGLs) and disproportionately enlarged subarachnoid space hydrocephalus (DESH), a specific morphological finding, were used and known in 39.4% and 38% of MCDs, respectively. Logistic regression analysis with "Refer the patient to other hospitals (e.g., hospitals with neurosurgery departments) when iNPH is suspected." as the response variable and (a) using the iNPHGLs, (b) knowledge of DESH, (c) confidence regarding DESH, (d) difficulty with performing brain magnetic resonance imaging, (e) knowledge of the methods of CSF tap test, (f) absence of physician who can perform lumbar puncture, and (g) experience of being told by neurosurgeons that referred patients are not indicated for shunt surgery as explanatory variables revealed that the last two factors were significant predictors of patient referral from MCDs to other hospitals.
Sufficient differential or comorbid diagnosis using CSF tap test was performed in a few MCDs. Medical care for patients with iNPH in MCDs may be improved by having dementia specialists perform CSF tap tests and share the eligibility criteria for shunt surgery with neurosurgeons.
特发性正常压力脑积水(iNPH)的治疗需要痴呆症专家和神经外科医生之间的合作。痴呆症专家的作用是将iNPH患者与其他痴呆症疾病患者区分开来,并确定是否有其他痴呆症疾病与iNPH合并存在。我们在痴呆症医疗中心(MCDs)进行了一项基于全国医院的iNPH问卷调查。
我们设计了一份问卷,以评估MCDs的医生如何评估和治疗因疑似iNPH导致认知障碍的患者,以及这些医生在评估和治疗患者过程中遇到的困难。问卷被发送到日本所有456家MCDs。
我们收到了来自279家MCDs的问卷(回复率:61.2%)。分别有96.8%、77.8%和98.2%的MCDs对患者进行了认知测试、iNPH三联征症状评估和形态学神经影像学检查。78.9%的MCDs将疑似iNPH的患者转诊至其他医院(如设有神经外科的医院),44家MCDs(15.8%)进行了脑脊液(CSF)穿刺测试。分别有39.4%和38%的MCDs使用并知晓iNPH指南(iNPHGLs)和一种特定的形态学表现——蛛网膜下腔不成比例扩大性脑积水(DESH)。以“疑似iNPH时将患者转诊至其他医院(如设有神经外科的医院)”作为因变量,以(a)使用iNPHGLs、(b)对DESH的了解、(c)对DESH的信心、(d)进行脑磁共振成像的困难程度、(e)对CSF穿刺测试方法的了解、(f)没有能够进行腰椎穿刺的医生以及(g)被神经外科医生告知转诊患者不适合进行分流手术的经历作为解释变量进行逻辑回归分析,结果显示最后两个因素是MCDs将患者转诊至其他医院的重要预测因素。
少数MCDs使用CSF穿刺测试进行了充分的鉴别或合并症诊断。让痴呆症专家进行CSF穿刺测试并与神经外科医生共享分流手术的入选标准,可能会改善MCDs中iNPH患者的医疗护理。